Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Indisputable: Humira, Biologics Dominate Pharma Sales In 2017

05 Apr 2018

• By John Hodgson

map — Global drug sales - biologics take over at last

Related Content

End In Sight: Humira Stacks Up 20 Years Of US Market Exclusivity

05 Apr 2018

Related Companies

AbbVie Inc.

Amgen, Inc.

Bristol Myers Squibb Company

Roche Holding AG

Eli Lilly and Company

Merck & Co., Inc.

AstraZeneca PLC

Boehringer Ingelheim GmbH

Gilead Sciences, Inc.

Novartis AG

Pfizer Inc.

Otsuka Holdings Co., Ltd.

Johnson & Johnson

GSK plc

Additional Topics

Biologics Commercial Sales & Earnings BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.